Get Real Time Here
| Open18.970 | Close18.480 |
| Vol / Avg.716.712K / 925.461K | Mkt Cap2.353B |
| Day Range18.335 - 18.970 | 52 Wk Range8.710 - 20.540 |
NeoGenomics Stock (NASDAQ:NEO), Quotes and News Summary
NeoGenomics Stock (NASDAQ: NEO) stock price, news, charts, stock research, profile.
| Open18.970 | Close18.480 |
| Vol / Avg.716.712K / 925.461K | Mkt Cap2.353B |
| Day Range18.335 - 18.970 | 52 Wk Range8.710 - 20.540 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.080 | 0.000 | 0.0800 | ||||
| REV | 142.000M | 151.954M | 9.954M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-11-08 | Morgan Stanley | Tejas Savant | Maintains | Equal-WeightEqual-Weight | Raises | 16.00 | 17.00 |
| 2023-11-07 | Needham | Mike Matson | Reiterates | BuyBuy | Maintains | - | 21.00 |
| 2023-10-24 | Morgan Stanley | Tejas Savant | Maintains | Equal-WeightEqual-Weight | Lowers | 18.00 | 16.00 |
| 2023-10-23 | Goldman Sachs | Matthew Sykes | Maintains | BuyBuy | Lowers | 19.00 | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NEO | NeoGenomics | -3.3% | 2.4B |
| CVS | CVS Health | 3.9% | 91.6B |
| CHE | Chemed | -0.36% | 8.7B |
| AGTI | Agiliti | -11.41% | 1B |
| HIMS | Hims & Hers Health | -1.24% | 1.9B |
How do I buy NeoGenomics (NEO) stock?
You can purchase shares of NeoGenomics (NASDAQ: NEO) through any online brokerage.
Who are NeoGenomics's (NEO) competitors?
Other companies in NeoGenomics’s space includes: CVS Health (NYSE:CVS), Chemed (NYSE:CHE), Agiliti (NYSE:AGTI), Hims & Hers Health (NYSE:HIMS) and Privia Health Gr (NASDAQ:PRVA).
What is the target price for NeoGenomics (NEO) stock?
The latest price target for NeoGenomics (NASDAQ: NEO) was reported by Morgan Stanley on Wednesday, November 8, 2023. The analyst firm set a price target for 17.00 expecting NEO to fall to within 12 months (a possible -7.91% downside). 25 analyst firms have reported ratings in the last year.
Current Stock Price for NeoGenomics (NEO)?
The stock price for NeoGenomics (NASDAQ: NEO) is $18.46 last updated December 5, 2023 at 10:46 PM UTC.
Does NeoGenomics (NEO) pay a dividend?
There is no dividend information for NeoGenomics.
When is NeoGenomics (NASDAQ:NEO) reporting earnings?
NeoGenomics’s Q4 earnings are confirmed for Thursday, February 22, 2024.
Is NeoGenomics (NEO) going to split?
There is no upcoming split for NeoGenomics.
What sector and industry does NeoGenomics (NEO) operate in?
NeoGenomics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.